Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Assets Average (2016 - 2025)

Historic Assets Average for Perspective Therapeutics (CATX) over the last 14 years, with Q3 2025 value amounting to $302.8 million.

  • Perspective Therapeutics' Assets Average fell 2207.29% to $302.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $302.8 million, marking a year-over-year decrease of 2207.29%. This contributed to the annual value of $219.5 million for FY2024, which is 18143.76% up from last year.
  • Per Perspective Therapeutics' latest filing, its Assets Average stood at $302.8 million for Q3 2025, which was down 2207.29% from $320.0 million recorded in Q2 2025.
  • Over the past 5 years, Perspective Therapeutics' Assets Average peaked at $388.5 million during Q3 2024, and registered a low of $43.4 million during Q1 2021.
  • Its 5-year average for Assets Average is $167.2 million, with a median of $104.2 million in 2023.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 73189.43% in 2021, then crashed by 2207.29% in 2025.
  • Perspective Therapeutics' Assets Average (Quarter) stood at $68.0 million in 2021, then decreased by 11.28% to $60.3 million in 2022, then surged by 72.77% to $104.2 million in 2023, then soared by 251.35% to $366.1 million in 2024, then dropped by 17.3% to $302.8 million in 2025.
  • Its Assets Average was $302.8 million in Q3 2025, compared to $320.0 million in Q2 2025 and $335.2 million in Q1 2025.